Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
Status:
Terminated
Trial end date:
2019-01-11
Target enrollment:
Participant gender:
Summary
This research study is studying radiation therapy in combination with an immunotherapy as a
possible treatment for metastatic hormone receptor (HR) positive, HER2-negative breast
cancer.
The interventions involved in this study are:
- Palliative Radiotherapy
- Pembrolizumab